XOLARIS: A 24-Month, Prospective, Natural History Study of 201 Participants with Retinitis Pigmentosa GTPase Regulator-Associated X-Linked Retinitis Pigmentosa
MacLaren RE. et al, (2025), Ophthalmology Science, 5, 100595 - 100595
Assessment of Visual Function with Cotoretigene Toliparvovec in X-Linked Retinitis Pigmentosa in the Randomized XIRIUS Phase 2/3 Study
Lam BL. et al, (2024), Ophthalmology, 131, 1083 - 1093
Gene therapy for choroideremia using an adeno-associated viral vector encoding Rab escort protein 1: the REGENERATE open-label trial
Cehajic-Kapetanovic J. et al, (2024), Efficacy and Mechanism Evaluation, 1 - 59
Rescue of cone and rod photoreceptor function in a CDHR1-model of age-related retinal degeneration
Yusuf IH. et al, (2024), Molecular Therapy, 32, 1445 - 1460
A hypomorphic variant of choroideremia is associated with a novel intronic mutation that leads to exon skipping
Waldock WJ. et al, (2024), Ophthalmic Genetics, 45, 210 - 217
Optical Coherence Tomography Feature of Retinoschisis in CRB1-Associated Maculopathy
Bellingrath J-S. et al, (2024), JAMA Ophthalmology, 142, 158 - 158
The incidence, monitoring coverage and clinical characteristics of hydroxychloroquine retinopathy in the United Kingdom
Yusuf IH. et al, (2024), Eye (Basingstoke)
Outcomes and Adverse Effects of Voretigene Neparvovec Treatment for Biallelic RPE65-Mediated Inherited Retinal Dystrophies in a Cohort of Patients from a Single Center
Kiraly P. et al, (2023), Biomolecules, 13, 1484 - 1484
Hypomorphic CDHR1 variants may result in retinitis pigmentosa with relative preservation of cone function.
Farag S. et al, (2023), Ophthalmic Genet, 1 - 6
Correlation Between Fundus Autofluorescence Pattern and Retinal Function on Microperimetry in Choroideremia.
Poli FE. et al, (2023), Transl Vis Sci Technol, 12
Choroideremia: Toward Regulatory Approval of Retinal Gene Therapy.
Yusuf IH. and MacLaren RE., (2023), Cold Spring Harb Perspect Med, 13
Infographic: Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: the ANCHOR study.
Yusuf IH. et al, (2023), Eye (Lond)
Infographic: A randomized controlled study of ranibizumab in patients with choroidal neovascularization secondary to pathologic myopia: the RADIANCE study.
Yusuf IH. et al, (2023), Eye (London, England)
Infographic: Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation in patients with proliferative diabetic retinopathy (PDR): the CLARITY study.
Yusuf IH. et al, (2023), Eye (London, England)
Infographic: Comparing the effectiveness of bevacizumab to ranibizumab in patients with exudative age-related macular degeneration: the BRAMD study.
Yusuf IH. et al, (2023), Eye (London, England)
Infographic: Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy: two-year results from the Diabetic Retinopathy Vitrectomy Study.
Yusuf IH. et al, (2023), Eye (London, England)
Infographic: Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months: the VICI study.
Yusuf IH. et al, (2023), Eye (London, England)
Infographic: Panretinal photocoagulation vs intravitreous ranibizumab for proliferative diabetic retinopathy (PDR): DRCR.net Protocol S.
Yusuf IH. et al, (2023), Eye (London, England)
Infographic: Ranibizumab plus panretinal photocoagulation (PRP) versus PRP alone for high-risk proliferative diabetic retinopathy (PDR): the PROTEUS study.
Yusuf IH. et al, (2023), Eye (London, England)